These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16507432)

  • 1. Localized rhabdomyolysis after exertion in a cardiac transplant recipient on statin therapy.
    Biggs MJ; Bonser RS; Cram R
    J Heart Lung Transplant; 2006 Mar; 25(3):356-7. PubMed ID: 16507432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymptomatic statin-induced rhabdomyolysis after long-term therapy with the hydrophilic drug pravastatin.
    Schindler C; Thorns M; Matschke K; Tugtekin SM; Kirch W
    Clin Ther; 2007 Jan; 29(1):172-6. PubMed ID: 17379057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin specific toxicity in organ transplant recipients: case report and review of the literature.
    Bae J; Jarcho JA; Denton MD; Magee CC
    J Nephrol; 2002; 15(3):317-9. PubMed ID: 12113605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis.
    McAdams M; Staffa J; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):229-39. PubMed ID: 18175291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myotoxicity and rhabdomyolisis due to statins].
    Cohen LH
    Ned Tijdschr Geneeskd; 2002 Mar; 146(9):440-1; author reply 441. PubMed ID: 11901950
    [No Abstract]   [Full Text] [Related]  

  • 6. [Rhabdomyolysis as a side effect of simvastatin treatment].
    Iskra B; Zivko M; Kes P
    Acta Med Croatica; 2005; 59(4):325-8. PubMed ID: 16334740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of statin therapy in patients switched from cyclosporine a to sirolimus after cardiac transplantation.
    Aliabadi AZ; Mahr S; Dunkler D; Grömmer M; Zimpfer D; Wolner E; Grimm M; Zuckermann AO
    Transplantation; 2008 Dec; 86(12):1771-6. PubMed ID: 19104420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rhabdomyolysis probably caused by interaction between efalizumab and pravastatin].
    Cid Conde L; Silveria Cancela D
    Farm Hosp; 2007; 31(2):135-6. PubMed ID: 17590128
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk factors for statin-associated rhabdomyolysis.
    Schech S; Graham D; Staffa J; Andrade SE; La Grenade L; Burgess M; Blough D; Stergachis A; Chan KA; Platt R; Shatin D
    Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):352-8. PubMed ID: 16892458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transplant coronary artery disease--treatment with statins].
    Wolszakiewicz J; Bilińska M
    Pol Merkur Lekarski; 2004 May; 16(95):472-3. PubMed ID: 15518430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal rhabdomyolysis following the co-prescription of fusidic acid and pravastatin.
    Bachoumas K; Fiancette M; Lascarrou JB; Lacherade JC; Leclair F; Reignier J
    Med Mal Infect; 2015 Oct; 45(10):417-9. PubMed ID: 26472060
    [No Abstract]   [Full Text] [Related]  

  • 12. Rhabdomyolysis with atorvastatin and fusidic acid.
    O'Mahony C; Campbell VL; Al-Khayatt MS; Brull DJ
    Postgrad Med J; 2008 Jun; 84(992):325-7. PubMed ID: 18644925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical perspectives of statin-induced rhabdomyolysis.
    Alshekhlee A; Katirji B
    Am J Med; 2007 Dec; 120(12):e29; author reply e33. PubMed ID: 18060911
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients.
    Martin JE; Cavanaugh TM; Trumbull L; Bass M; Weber F; Aranda-Michel J; Hanaway M; Rudich S
    Clin Transplant; 2008; 22(1):113-9. PubMed ID: 18217912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin-associated rhabdomyolysis.
    Ardati A; Stolley P; Knapp DE; Wolfe SM; Lurie P
    Pharmacoepidemiol Drug Saf; 2005 Apr; 14(4):287. PubMed ID: 15782398
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanisms of rhabdomyolysis with statins].
    Magalhães ME
    Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():42-4. PubMed ID: 16400398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and cancer development.
    Duncan RE; El-Sohemy A; Archer MC
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1897-8. PubMed ID: 16103434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complete atrioventricular block due to hyperkalemia caused by rhabdomyolysis during treatment with statin].
    Grabka M; Wita K; Berger-Kucza A; Bochenek T; Turski M; Trusz-Gluza M
    Kardiol Pol; 2010 Dec; 68(12):1376-8; discussion 1379. PubMed ID: 21174295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rhabdomyolysis caused by pravastatin and type 1 macrocreatine kinase].
    Decoulx E; Millaire A; de Groote P; Mahieux G; Ducloux G
    Ann Cardiol Angeiol (Paris); 1993 May; 42(5):267-9. PubMed ID: 8368799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pravastatin-induced colitis.
    Mukhopadhya A; Gilmour H; Plevris J
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):810-2. PubMed ID: 18617789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.